Hutchin Hill Capital, LP - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Hutchin Hill Capital, LP ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$935,000
-18.9%
91,200
+3.3%
0.02%
-51.3%
Q2 2016$1,153,000
+137.2%
88,300
+99.9%
0.04%
+178.6%
Q1 2016$486,000
-36.0%
44,170
-42.9%
0.01%
-30.0%
Q2 2015$759,000
+20.7%
77,300
+8.9%
0.02%
+17.6%
Q1 2015$629,000
+208.3%
71,000
+139.9%
0.02%
+112.5%
Q3 2014$204,00029,6000.01%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders